How long should aspirin (acetylsalicylic acid) be held prior to surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Perioperative Aspirin Management

For most elective surgeries, aspirin should be discontinued 3-7 days before the procedure, with the exact timing depending on the type of surgery and the patient's thrombotic risk. 1

Surgery-Specific Recommendations

High Bleeding Risk Procedures

  • Neurosurgery/Spinal/Intracranial surgery: Stop aspirin 7 days before surgery 1
  • Non-cardiac surgery with high bleeding risk: Stop aspirin ≤7 days before surgery (typically 3-5 days) 1

Low Bleeding Risk Procedures

  • Minor dental/dermatologic procedures and cataract surgery: Continue aspirin throughout 1
  • Coronary artery bypass grafting (CABG): Continue aspirin throughout 2, 1
  • Cesarean delivery: Continue aspirin throughout 1

Special Considerations for Coronary Stents

Drug-Eluting Stents (DES)

  • If possible, delay elective surgery until at least 12 months after DES placement 2
  • If surgery cannot be delayed:
    • Continue aspirin throughout the perioperative period if at all possible 2
    • If both aspirin and thienopyridine must be stopped due to very high bleeding risk:
      • Stop no sooner than 5 days before surgery
      • Restart as soon as possible after surgery, within 5 days 2

Bare-Metal Stents (BMS)

  • Delay elective surgery for at least 4-12 weeks after BMS placement 2
  • Continue aspirin throughout the perioperative period if possible 2

Resumption of Aspirin Therapy

  • Resume aspirin within 24 hours after surgery once adequate hemostasis is achieved 1
  • For patients with high cardiovascular risk, consider earlier resumption 1

Urgent Surgery Considerations

  • For urgent surgeries where aspirin cannot be stopped in advance:
    • Proceed with awareness of increased bleeding risk
    • Consider platelet transfusion if significant bleeding occurs intraoperatively 1

Specific Recommendations for Cardiac Surgery

  • For CABG: Non-enteric-coated aspirin (81-325 mg daily) should be administered preoperatively 2
  • For patients on dual antiplatelet therapy requiring CABG:
    • Clopidogrel and ticagrelor should be discontinued at least 5 days before elective surgery 2
    • Prasugrel should be discontinued at least 7 days before elective surgery 2
    • For urgent CABG, clopidogrel and ticagrelor should be discontinued for at least 24 hours 2

Risk Assessment

  • For patients on aspirin for secondary prevention of cardiovascular disease, the risk of thrombotic events with discontinuation (approximately 10% risk of all vascular events) must be weighed against the bleeding risk 3
  • For patients on aspirin for primary prevention, the drug can be safely discontinued 7 days before surgery 1

Important Caveats

  • Aspirin induces irreversible inactivation of platelet function that lasts 7-10 days 4
  • There is no scientific evidence supporting the routine withdrawal of aspirin in all patients 5-10 days prior to surgery 4
  • For heart patients in particular, continued use of aspirin may be beneficial unless the bleeding risk is extremely high 4
  • For most surgeries except neurosurgery and procedures in closed spaces, the cardiovascular benefits of continuing aspirin may outweigh the bleeding risks 5

Remember that these recommendations represent general guidelines, and the final decision should consider the specific surgical procedure, the patient's cardiovascular risk, and the potential consequences of perioperative bleeding.

References

Guideline

Perioperative Aspirin Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antiplatelet agents in the perioperative period.

Archives of surgery (Chicago, Ill. : 1960), 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.